In January 2017, Boursier et al. developed a novel algorithm-the easy Liver Fibrosis Test (eLIFT), a sum of points attributed to age, gender, gamma-glutamyl transpeptidase (GGT), aspartate transaminase (AST), platelet count, and prothrombin time, for the diagnosis of advanced fibrosis and cirrhosis in the training set of 2503 patients with chronic liver disease (CLD)6. This evidence concerns the gene F2 and Hepatic fibrosis.